Barrington Research Upgrades Haemonetics (HAE) to Outperform
Tweet
Share
E-mailGet Alerts HAE Hot Sheet
Price: $72.53 --0%
Rating Summary:
10 Buy, 10 Hold, 0 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 4 | Down: 11 | New: 23
Rating Summary:
10 Buy, 10 Hold, 0 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 4 | Down: 11 | New: 23
Join SI Premium – FREE
Barrington Research upgraded Haemonetics (NYSE: HAE) from Market Perform to Outperform with a price target of $41.00.
For an analyst ratings summary and ratings history on Haemonetics click here. For more ratings news on Haemonetics click here.
Shares of Haemonetics closed at $36.84 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Wolfe Research Upgrades Target (TGT) to Outperform
- Piper Sandler Upgrades Synopsys (SNPS) to Overweight
- UBS Upgrades Intermedia Capital Group (ICG:LN) (ICGUF) to Buy
Create E-mail Alert Related Categories
UpgradesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
